
Johns Hopkins University in Baltimore will enroll up to 200 adults who received a kidney transplant in the past year and had no or low antibody response to two doses of the Moderna or Pfizer COVID-19 vaccine in a study to see if a third dose of the vaccine induces a protective immune response, the National Institutes of Health announced.